Samsung Group In Talks To Buy U.S. Drugmaker Biogen - Korea Economic Daily

Samsung Group In Talks To Buy U.S. Drugmaker Biogen – Korea Economic Daily

  (Reuters) -South Korea’s Samsung Group is in talks to buy U.S. drugmaker Biogen Inc, Korea Economic Daily reported https://www.kedglobal.com/newsView/ked202112290011?lang=us on Wednesday, citing investment banking sources. The report said Biogen approached Samsung to buy its shares, which could be valued at more than $42 billion. The drugmaker is valued at $34.67 billion, according to Refinitiv…

Read More
Dollar Dips In Quiet Holiday Trading

Dollar Dips In Quiet Holiday Trading

By John McCrank NEW YORK (Reuters) -The dollar edged lower in thin holiday trading on Wednesday, while the safe-haven yen touched a one-month low as investors looked beyond a surge in Omicron cases and favored riskier currencies. The dollar index, which tracks the greenback against six global peers, was down 0.206% at 95.932, having turned…

Read More
Purdue Bankruptcy Judge Extends Temporary Litigation Shield For Sacklers

Purdue Bankruptcy Judge Extends Temporary Litigation Shield For Sacklers

  By Maria Chutchian (Reuters) – A bankruptcy judge has extended temporary protections against opioid-related litigation for the Sackler family members who own Purdue Pharma until Feb. 1 after another judge overturned the OxyContin maker’s bankruptcy settlement this month. U.S. Bankruptcy Judge Robert Drain in White Plains, New York, extended the litigation shield on Wednesday,…

Read More